Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | December 15, 2015 |
| Target | Whitehouse Laboratories |
| Sector | Life Science |
| Buyer(s) | Curia |
| Deal Type | Add-on Acquisition |
| Deal Value | 54M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1991 |
| Sector | Life Science |
| Employees | 2,220 |
| Revenue | 402M USD (2015) |
Curia is a contract development and manufacturing organization (CDMO) providing services from drug discovery through development and manufacturing for small molecules, generic APIs, and biologics. The company draws on many years of experience and operates globally with integrated facilities in North America, Europe, and Asia. Curia was founded in 1991 and is headquartered in Albany, New York.
| Deal Context for Buyer | # |
|---|---|
| Overall | 7 of 11 |
| Sector: Life Science | 5 of 9 |
| Type: Add-on Acquisition | 6 of 8 |
| State: New Jersey | 1 of 2 |
| Country: United States | 4 of 7 |
| Year: 2015 | 3 of 3 |
| Size (of disclosed) | 5 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-07-16 |
Gadea Grupo Farmacéutico SL
Valladolid, Spain Gadea Grupo Farmacéutico SL (Gadea Pharmaceutical Group) is a technically complex active pharmaceutical ingredients (APIs) and finished drug product. |
Buy | $174M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-05-05 |
Archimica
Lodi, Italy Archimica offers small- to large-scale commercial manufacturing as well as analytical support for the global biopharmaceutical market. The company is specialized in custom synthesis and the manufacture of active pharmaceutical ingredients (“APIs”). Archimica was founded in 1946 and is based in Lodi, Italy. |
Buy | $358M |
